
[Cancer Research 49, 877-882, February 15, 1989]
© 1989 American Association for Cancer Research
Cyclosporin Immunosuppression Mediated by Calcium/Sodium Imbalance1
P. M. Kimball2 and
Stewart Sell
Departments of Surgery, Immunology and Organ Transplantation [P. M. K.], and Pathology/Laboratory Medicine [S. S.], University of Texas Health Science Center, Houston, Texas 77030
Cyclosporin immunosuppression is mediated by a calcium/sodium excess during G0 which inhibits further cell cycle progression. The consequences of cyclosporin on electrolyte content were measured in T-lymphocytes stimulated with concanavalin A. Cyclosporin caused an excessive accumulation of extracellular calcium for the first 4 h of lectin stimulation. The nonpermissive calcium content resulted from a reduction in the rate of calcium efflux from the cell. Because cyclosporin did not affect calcium translocation via ATPase but did permit excessive amounts of sodium to enter the resting cell we hypothesized that the calcium excess is caused by a shut-down of the Ca2+/Na+ antiport during the first hours of lectin stimulation. The subsequent normalization of calcium content is coincident with the onset of mRNA synthesis, which suggests development of compensatory mechanisms to alleviate the calcium burden. The G0 calcium excess did not affect other transductive events such as ligand recognition, phosphatidyl inositol metabolism, or adenylate cyclase activation. This study points to the causative mechanism of cyclosporin immunosuppression and emphasizes the dynamic role of ions as modulators of normal cell proliferation.
1 Supported by NIH Grant A121721.
2 To whom requests for reprints should be addressed, at Department of Surgery, Immunology and Organ Transplantation, University of Texas Health Science Center, Houston, TX 77030.
Received 7/12/88.
Revised 9/30/88.
Accepted 11/ 7/88.
This article has been cited by other articles:

|
 |

|
 |
 
V. Calderaro, M. Boccellino, G. Cirillo, L. Quagliuolo, D. Cirillo, and A. Giovane
Cyclosporine A Amplifies Ca2+ Signaling Pathway in LLC-PK1 Cells through the Inhibition of Plasma Membrane Ca2+ Pump
J. Am. Soc. Nephrol.,
June 1, 2003;
14(6):
1435 - 1442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Blaustein and W. J. Lederer
Sodium/Calcium Exchange: Its Physiological Implications
Physiol Rev,
July 1, 1999;
79(3):
763 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1989 by the American Association for Cancer Research.